Plant Derivative Could Help Refine Cancer Treatment 08 February 2010 MCG researchers are seeking to refine cancer treatment with an anti-inflammatory plant derivative long used in Chinese medicine.
TGen and Geisinger Health System Announce Strategic Partnership to Shape Future of Personalized Medicine 04 February 2010 Obesity and diabetes focus of first study
NextGen Sciences to Develop and Validate Protein Biomarker Assays for Takeda Pharmaceuticals 02 February 2010 NextGen Sciences and Takeda Pharmaceutical Company Limited (“Takeda”) have entered into an agreement under which NextGen Sciences will develop validated protein biomarker assays to be used in Takeda’s preclinical and clinical studies to support their drive towards personalized medicine.
Diaceutics Identifies Critical Market Drivers for Personalized Medicine Development 29 January 2010 Special Report Details Business and Market Issues Facing Drug-Makers Seeking to Maximize ROI for Targeted Drugs and Associated Diagnostics.
DNASTAR Joins BioIT Alliance 27 January 2010 DNASTAR, Inc. and the BioIT Alliance today announced the expansion of the BioIT Alliance program to include DNASTAR, a software company that has been meeting the sequence assembly and analysis needs of life scientists for more than 25 years.
Resverlogix Commences Phase 2 Atherosclerosis Clinical Trial 24 December 2009 Cleveland Clinic initiates dosing in ASSERT Trial in patients with stable coronary artery disease.
Anemia Drug Not Helpful for Kidney Disease Patients, UT Southwestern Researcher Reports 24 December 2009 Study concluds that the anemia drug darbepoetin alfa works no better than a placebo in several applications previously thought to be promising.
PMC Urges FDA to Clarify Rules for Drug-Diagnostic Combinations 24 December 2009 PMC urges the agency to clarify its requirements for approving drug-diagnostic combinations.